PIT
- Product code
- PIT
- Device name
- Leishmania Spp. Antigen Detection Assay
- Device class
- Class 1
- 21 CFR
- 21 CFR 866.3870
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- Flag
- Third-party review eligible
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
An in vitro diagnostic test for the detection of Leishmania spp. antigens to aid in the diagnosis of Leishmania spp. infection.
Official FDA classification page: PIT
Classification and pathway per current FDA publications. Data from openFDA (CC0).